Skip to content
  • Home
  • Login
  • Register
The Journal of Commercial Biotechnology Logo
  • Home
  • Current
  • Archive
  • Ethical Guidelines
    • Author Guidelines
    • Submission Checklist
    • PMC Deposit Process/Matrix
    • Privacy Statement
  • About
    • About the Journal
    • Editorial Team
    • Indexing
    • Publication Fee
    • Open Access
  • Contact Us

JCB, Volume 23, Number 4, 2017

Commentary
Vol.23 No. 4 (2017)

Personalized Medicine Needs Enlightened Regulation To Realize Its Potential

Henry I. Miller

Precision, or personalized, medicine, reflects that treatments -- especially those using biopharmaceuticals -- are gradually shifting from a relatively imprecise "one size fits all" appro

  • Abstract
  • Download PDF
Commentary
Vol.23 No. 4 (2017)

Can there be value-based medicine without … values?

Peter J. Pitts

“Value-based” is the new, hot prefix. Value-based medicine, value-based insurance design, value-based contracting. It seems that everyone agrees that everything should be based on “

  • Abstract
  • Download PDF
Commentary
Vol.23 No. 4 (2017)

Biotechnology Can Address the Mystery and Urgency of Alzheimer’s Disease

Mina Marmor

Alzheimer’s disease (AD), a scourge that in time could virtually bankrupt healthcare systems worldwide, is one of the most intensively researched areas of medicine. Because of t

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Enzymatic approach for bioremediation of effluent from pulp and paper industry by thermo alkali stable laccase from Bacillus tequilensis SN4

Sonica Sondhi

Treatments of industrial effluent/s by enzymes offer significant advantage over the use of microorganisms. However they have not been explored for the bioremediation of effluent from pulp

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Application of transgenic biotechnology based on public participation system in China

Mei An

In recent years, the application of transgenic biotechnology in China has become more and more extensive, but the matched public participation system construction is not optimistic; d

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Statistical Optimization of the production of protease from Bacillus sp. MSK-01 in submerged fermentation

Kulwant Kaur

Protease has been in increasing demand in industries due to its hydrolytic nature. In industries, high yield of enzyme is required to meet the industrial need at a relatively cheaper cost

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Research on Safety Hazard Control of Genetically Modified Organisms Based on Compensation Laws

Chensong Fei

In this paper, we firstly analyzed the categories and characteristics of safety hazards of genetically modified organisms. Then, we summarized and compared the laws on safety hazard comp

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

A qualitative study among potential manufacturers on the development of ‘Made in Malaysia’ biological products: Challenges and proposed solutions

Yvonne Siew Khoon Khoo

Aim: To examine the challenges in development of biological products among Malaysian pharmaceutical manufacturers.

Methods: We conducted in-depth interviews (IDIs) with senior manag

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

International trade legal issues induced by biotechnology and the countermeasures

Haiying Zheng

Genetically modified products have gradually entered people’s life because of the rapid development of biotechnology. With the perfection and progress of relevant technologies, gene

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Research on Biotech Venture Capital Project Evaluation

Zheng Li

Biotechnology has been widely used in medicine, environmental protection and food gene research fields, which is playing an increasingly important role in improving the human survival

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

A Study on Medical Biotechnology System from Legal Perspective

Yeung Lap Fu

With the progress and development of science and technology, medical biotechnology has made great progress, which created an objective market and lucrative returns for the medical and

  • Abstract
  • Download PDF
Articles
Vol.23 No. 4 (2017)

Impression Products, Inc. v. Lexmark International, Inc.: Is US Supreme Court's Ruling A Pointer To Indian Patent Law On Parallel Imports?

Dinesh Kumar Sharma

This article attempts to look at the recent significant 7-1 ruling dated May 30, 2017 handed down by the Supreme Court of the United States in Impression Products, Inc.  v. Lexmark Internat

  • Abstract
  • Download PDF

Copyright © 2021 thinkBiotech Limited UK
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

thinkBiotech Limited
Journal of Commercial Biotechnology
63-66 Hatton Garden, London EC1N 8LE,
United Kingdom

GoDaddy SiteSealWebTrust
Go to Top